What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients

被引:22
|
作者
Wang, Wen [1 ]
Liu, Hui [1 ]
Li, Guoli [2 ,3 ,4 ,5 ]
机构
[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Cardiothorac Surg, Affiliated Hosp 1, Changsha, Peoples R China
[2] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, Affiliated Hosp 1, Changsha, Peoples R China
[3] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, Affiliated Hosp 1, Changsha, Peoples R China
[4] Changsha Clin Res Ctr Kidney Dis, Changsha, Peoples R China
[5] Hunan Clin Res Ctr Chron Kidney Dis, Changsha, Peoples R China
来源
关键词
lung adenocarcinoma; lung squamous cell carcinoma; clinicopathologic characteristics; radiological features; laboratory data; PLATELET COUNT; CANCER; PROGNOSIS;
D O I
10.3389/fendo.2022.947443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundLung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the two most common subtypes of lung cancer. Previously, they were categorized into one histological subtype known as non-small cell lung cancer (NSCLC) and often treated similarly. However, increasing evidence suggested that LUAD and LUSC should be classified and treated as different cancers. But yet, detailed differences in clinical features between LUAD and LUSC have not been well described. MethodsA cohort of 142 Chinese patients with 111 LUAD and 31 LUSC cases were consecutively enrolled from April 2019 to October 2020 in Hunan Provincial People's Hospital. The clinical features of the patients were retrospectively analyzed and compared in the terms of general information, clinicopathologic characteristics, imaging findings and laboratory data. ResultsIn comparison with LUAD, LUSC patients had a significantly higher proportion of males, smokers, drinkers, higher-stage cases. The mean tumor size in LUSC patients was significantly larger than that in LUAD patients. Compared with LUAD patients, more of patients with LUSC had cough, fever and abundant sputum symptoms. Besides that, more bacterial infections and fungal infections were found in LUSC patients than that in LUAD patients. Imaging data shows that ground-glass opacity and patchy shadows in radiological films were more frequent in LUAD patients than that in LUSC patients. In addition to initial laboratory data, LUSC patients had higher levels of leukocytes, platelets, and creatinine that of LUAD patients. ConclusionsTogether, these results suggested that there exist distinct differences between LUAD and LUSC subtypes; LUSC may be a more malignant type in comparison with LUAD. Our findings may have potential implications in clinical settings. However, further multicenter studies are needed to validate these findings in a larger sample size.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Radiomics in distinguishing between lung adenocarcinoma and lung squamous cell carcinoma: a systematic review and meta-analysis
    Shi, Lili
    Zhao, Jinli
    Wei, Zhichao
    Wu, Huiqun
    Sheng, Meihong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma
    Li, Piaopiao
    Yuan, Hui
    Kuang, Xuemei
    Zhang, Tingting
    Ma, Lei
    MEDICINE, 2022, 101 (47) : E31798
  • [23] Integrative Analysis of Methylation and Gene Expression in Lung Adenocarcinoma and Squamous Cell Lung Carcinoma
    Zhang, Hao
    Jin, Zhou
    Cheng, Ling
    Zhang, Bin
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [24] Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese Patients
    Pan, Lulu
    Wang, Xijun
    Yang, Longhai
    Zhao, Lei
    Zhai, Linhui
    Xu, Junyu
    Yang, Yikun
    Mao, Yousheng
    Cheng, Shujun
    Xiao, Ting
    Tan, Minjia
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Differential characteristics of fibroblasts between lung adenocarcinoma and squamous cell carcinoma
    Hirano, Yuta
    Nakayama, Jun
    Yamamoto, Tomofumi
    Fujita, Yu
    Araya, Jun
    Yamamoto, Yusuke
    CANCER SCIENCE, 2024, 115 : 1840 - 1840
  • [26] Genomic features of Chinese lung squamous cell carcinoma patients
    Zhao, Z.
    Chen, Y.
    Kong, W.
    Yu, Z.
    He, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S253 - S253
  • [27] Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Dong, Yanting
    Li, Shicheng
    Sun, Xiao
    Wang, Yuanyong
    Lu, Tong
    Wo, Yang
    Leng, Xiaoliang
    Kong, Dezhi
    Jiao, Wenjie
    ONCOTARGETS AND THERAPY, 2020, 13 : 11111 - 11124
  • [28] Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma
    Yoshino, I
    Osoegawa, A
    Yohena, T
    Kameyama, T
    Oki, E
    Oda, S
    Maehara, Y
    RESPIRATORY MEDICINE, 2005, 99 (03) : 308 - 312
  • [29] EGFR TKI Erlotinib in Patients with Advanced Squamous Cell Carcinoma of the Lung: A Retrospective Analysis from India
    Arya, Devavrat
    Singhal, Manish K.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S761 - S761
  • [30] Bioinformatics Analysis Reveals Connection of Squamous Cell Carcinoma and Adenocarcinoma of the Lung
    Fan, Wei-Dong
    Zhang, Xian-Quan
    Guo, Hui-Lin
    Zeng, Wei-Wei
    Zhang, Ni
    Wan, Qian-Qian
    Xie, Wen-Yao
    Cao, Jin
    Xu, Chang-Hua
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1477 - 1482